Health at a Glance 2013
Hide / Show Abstract

Health at a Glance 2013

OECD Indicators

This seventh edition of Health at a Glance provides the latest comparable data on different aspects of the performance of health systems in OECD countries. It provides striking evidence of large variations across countries in health costs, health activities and health results of health systems. Key health indicators provide information on health status including suicide and life expectancy, the determinants of health, health care activities and health expenditure and financing in OECD countries. Each health indicator in the book is presented in a user-friendly format, consisting of charts illustrating variations across countries and over time, brief descriptive analyses highlighting the major findings conveyed by the health data, and a methodological box on the definition of the indicator and any limitations in data comparability.

Click to Access: 
    http://oecd.metastore.ingenta.com/content/health_glance-2013-en/00/01/index.html
  • WEB
  • http://oecd.metastore.ingenta.com/content/8113161e.pdf
  • PDF
  • http://oecd.metastore.ingenta.com/content/812013161f1.epub
  • ePUB
  • http://www.keepeek.com/Digital-Asset-Management/oecd/social-issues-migration-health/health-at-a-glance-2013_health_glance-2013-en
  • READ
 
Chapter
 

Mortality following stroke You or your institution have access to this content

English
Click to Access: 
    http://oecd.metastore.ingenta.com/content/health_glance-2013-en/05/04/index.html
  • WEB
  • http://oecd.metastore.ingenta.com/content/8113161ec046.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/social-issues-migration-health/health-at-a-glance-2013/mortality-following-stroke_health_glance-2013-46-en
  • READ
Author(s):
OECD

Hide / Show Abstract

Stroke and other cerebrovascular diseases accounted for over 8% of all deaths in OECD countries. Ischemic stroke represents around 85% of all cerebrovascular disease cases. It occurs when the blood supply to a part of the brain is interrupted, leading to a necrosis (i.e. the cells that die) of the affected part. Treatment for ischemic stroke has advanced dramatically over the last decade. Clinical trials have demonstrated clear benefits of thrombolytic treatment for ischemic stroke as well as receiving care in dedicated stroke units to facilitate timely and aggressive diagnosis and therapy for stroke victims (Hacke et al., 1995; Seenan et al., 2007). Despite their clear clinical benefit, there is widespread variability in access to stroke units across and within countries (AIHW, 2013; Kapral et al., 2011; Indredavik, 2009).

Also available in French
 
Visit the OECD web site